Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent

Circulation

Volumn 96, Issue 3, 1997, Pages 959-967

  Firschke, Christian ^a,b   Lindner, Jonathan R ^a   Wei, Kevin ^a   Goodman, Norman C ^a   Skyba, Danny M ^a   Kaul, Sanjiv ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Contrast media; Echocardiography; Infarction; Occlusion; Stenosis

Indexed keywords

ALBUMIN MICROSPHERE TC 99M; CONTRAST MEDIUM; FS 069; MACROSALB TC 99M; MICROSPHERE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; DOG; ECHOCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE; HYPEREMIA; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CONTRAST MEDIA; CORONARY CIRCULATION; CORONARY DISEASE; DOGS; ECHOCARDIOGRAPHY; HYPEREMIA; INJECTIONS, INTRAVENOUS; MICROSPHERES; MYOCARDIAL INFARCTION;

EID: 0030877547     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Kemper AJ, O'Boyle JE, Cohen CA, Taylor A, Parisi AF. Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and the necrotic area remaining after myocardial reperfusion. Circulation. 1984;70: 309-317.
2. Kaul S, Pandian NG, Okada RD, Pohost GM, Weyman AE. Contrast echocardiography in acute myocardial ischemia, I: in-vivo determi~ nation of total left ventricular 'area at risk.' J Am Coll Cardiol. 1984; 4:1272-1282.
3. Kaul S, Glasheen W, Ruddy TD, Pandian NG, Weyman AE, Okada RD. The importance of defining left ventricular 'area at risk' in vivo during acute myocardial infarction: an experimental evaluation utilizing myocardial contrast two-dimensional echocardiography. Circulation. 1987;75:1249-1260.
4. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Characterization of spatial patterns of flow within the reperfused myocardium using myocardial contrast echocardiography: implications in determining the extent of myocardial salvage. Circulation. 1993;88: 2596-2606.
5. Villanueva FS, Glasheen WP, Sklenar J, Kaul S. Assessment of risk area during coronary occlusion and infarct size after reperfusion with myocardial contrast echocardiography using left and right atrial injections of contrast. Circulation. 1993;88:596-604.
6. Ismail S, Jayaweera AR, Goodman NC, Camarano GP, Skyha DM, Kaul S. Detection of coronary artery stenoses and quantification of blood flow mismatch during coronary hyperemia with myocardial contrast echocardiography. Circulation. 1995;91:821-830.
7. Keller MW, Glasheen WP, Smucker ML, Burwell LR, Watson DD, Kaul S. Myocardial contrast echocardiography in humans. II: assessment of coronary blood flow reserve. J Am Coll Cardiol. 1988;12: 924-935.
8. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 1992;85:1699-1705.
9. Ragosta M, Camarano GP, Kaul S, Powers E, Gimple LW. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation. 1994;89:2562-2569.
10. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell L, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992; 327:1825-1831.
11. Porter T, Xie F, Kilzer K. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial contrast which correlates with coronary blood flow. J Am Soc Echocardiogr. 1995;8: 710-718.
12. Lindner JR, Firschke C, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial contrast echocardiography during acute myocardial infarction using intermittent harmonic imaging and intravenous MRX-115. Circulation. 1996;94(suppl I):I-575. Abstract.
13. Skyba DM, Camarano G, Goodman NC, Price RJ, Skalak TC, Kaul S. Hemodynamic characteristics, myocardial kinetics, and microvascular rheology of FS-069, a second generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol. 1996;28:1292-1300.
14. Mulvaugh SL, Foley DA, Aeschbacher BC, Klarich KK, Seward JB. Second harmonic imaging of an intravenously administered echocardiographic contrast agent: visualization of coronary arteries and measurement of coronary blood flow reserve. J Am Coll Cardiol. 1996;27:1519-1525.
15. Wei K, Skyba DM, Firschke C, Lindner JR, Jayaweera AR, Kaul S. Interaction between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol. 1997;29:1081-1088.
16. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a non-linear ultrasonic contrast agent. Ultrason Imaging. 1992;14:134-158.
17. De Jong N. Higher harmonics of vibrating gas-filled microspheres. In: de Jong N, ed. Acoustic Properties of Ultrasound Contrast Agents. Woerden, Netherlands: Zuidam & Zonen BV; 1993:61-78.
18. Burns PN, Powers JE, Simpson DH, Uhlendorf V, Fritzsche T. Harmonic imaging with ultrasound contrast agents. Clin Radiol. 1996; 51(suppl I):50-55.
19. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation. 1995;92:2391-2395.
20. 2A receptor agonist. Circulation. 1996;94:1726-1732.
21. Heyman MA, Payne BD, Hoffman JI, Rudolf AM. Blood flow measurements with radionuclide labeled particles. Prog Cardiovasc Dis. 1977;20:52-79.
22. DeBoer LW, Strauss HW, Kloner RA, Rude RE, Davis RF, Maroko PR, Braunwald E. Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size after experimental coronary artery occlusion. Proc Natl Acad Sci U S A. 1980;77:6119-6123.
23. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981;101:593-600.
24. Albers VM. Underwater Acoustic Handbook. State College, Pa: The Pennsylvania State University Press; 1960.
25. Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In-vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography: comparison with radiolabeled red blood cells. Circ Res. 1994;74: 1157-1165.
26. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 1974;34:48-55.
27. Wu X, Ewert DL, Liu Y, Ritman EL. In vivo relation of intramyocardial blood volume to myocardial perfusion: evidence supporting microvascular site for autoregulation. Circulation. 1992;85: 730-737.
28. Lindner JR, Skyba DM, Goodman NC, Jayaweera AR, Kaul S. Changes in myocardial blood volume with graded coronary stenosis: an experimental evaluation using myocardial contrast echocardiography. Am J Physiol. 1997;272:H567-H575.
29. Eigler NL, Schuhlen H, Whiting JS, Plaff JM, Zeiher A, Gu S. Digital angiographic impulse response analysis of regional myocardial perfusion: estimation of coronary flow, flow reserve, and distribution volume by compartmental transit time measurement in a canine model. Circ Res. 1991;68:870-880.
30. Canty JM, Judd RM, Brody AS, Klocke FJ. First-pass entry of non-ionic contrast agent into the myocardial extravascular space: effects on radiographic estimates of transit time and blood volume. Circulation. 1991;84:2071-2078.
31. Kaul S. Assessment of prognosis in patients with suspected coronary artery disease using planar thallium-201 imaging. In: Kapoor AS, Singh BN, eds. Prognosis and Risk Assessment in Cardiovascular Disease. London, UK: Churchill Livingstone; 1992:213-228.
32. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardial. 1995;26:1340-1347.
33. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974; 54:1496-1508.
34. Johnson WB, Malone SA, Pantely GA, Anselone CG, Bristow JD. No reflow and extent of infarction during maximal vasodilation in the porcine heart. Circulation. 1988;78:462-472.
35. Wei K, Firoozan S, Jayaweera AR, Linka A, Skyba DM, Kaul S. Ultrasound-induced microbubble destruction during venous infusion: a novel method for the quantification of myocardial blood flow with echocardiography. Circ Res. In press.
36. 99mTc-sestamibi single photon emission computed tomography. Circulation. In press.